1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment | Patent Number 09227946
US 09227946 B2Filled DateApr 1, 2014
Priority DateJun 16, 2006
Publication DateSep 4, 2014
Expiration DateJun 15, 2026
Inventor/ApplicantsRene Holm
Heidi Lopez de Diego
Andre Faldt
Heidi Lopez de Diego
Andre Faldt
ExaminesPOLANSKY, GREGG
Art Unit1621
Technology Center1600
Assignments
Law Firm
You must be logged in to view
LoginAttorneys
Subscription-Only
View Concierge ProgramEmpower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.